Patent Assignment
Reel/Frame 065334/0144
Assignment of Assignor's Interest
Recorded: 2023-10-25
Pages: 3
Assignor
DURING, MATTHEW
Executed: 2019-03-12
Assignee
OVID THERAPEUTICS INC.
441 9TH AVENUE, 14TH FLOOR, NEW YORK, NEW YORK, 10001
Covered Property
(1)
Use of (1S,3S)-3-Amino-4-(Difluoromethylidene) Cyclopentane-1-Carboxylic Acid and (S)-3-Amino-4-(Difluoromethylenyl)Cyclopent-1-Ene-1-Carboxylic Acid in the Treatment of Tinnitus, Acute Sensorineural Hearing Loss, Meniere’S Disease, Tourette’S Syndrome, Attention Deficit Hyperactivity Disorder and Addiction
Application:
18/455,813 →
Publication:
US 2023/0404955